|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, ALL/NHL, MYC BA, 8q24 Rearrangement, TC
Test CodeCPT Codes
88271 (x2), 88275<br>Restricted Client Code - Tech Only
Preferred Specimen
Minimum Volume
Other Acceptable Specimens
Instructions
Clinical history and reason for referral are required with test order. Prior therapy and transplant history should be provided with test order.
For bone marrow (1-3 mL) or whole blood (3-5 mL), use a green-top tube with sodium heparin. For lymph node biopsy, 5 x 5 mm in sterile container in Hanks' Ringers solution or culture medium with antibiotics. Transportation medium available upon request.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Transport Temperature
Specimen Stability
Methodology
Fluorescence in situ Hybridization
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Clinical Significance
This fluorescence in situ hybridization (FISH) test is used to identify rearrangements of the C-MYC region located on chromosome band 8q24 using the dual color breakapart (BA) DNA probe. This rearrangement is observed in a majority of Burkitt lymphomas.
100-200 interphase nuclei are examined microscopically for the suspected gene rearrangement. This test is useful for evaluation of suboptimal specimens or when a variant or cryptic rearrangement is suspected.